Navigation Links
Talyst Announces AutoSplit Contract Pharmacy at 340B Coalition
Date:6/29/2012

KIRKLAND, Wash., June 29, 2012 /PRNewswire/ -- Talyst, a leader in pharmacy automation, announces AutoSplit® Contract Pharmacy at the 16th  Annual 340B Coalition. The conference highlights will include sessions devoted to program integrity and audits, key considerations when developing contract pharmacy relationships, how the 340B program helps improve and expand patient care, and practical steps and policy solutions to address drug shortages.

AutoSplit Contract Pharmacy allows health systems to capture additional 340B savings from hospital scripts dispensed at retail pharmacies. The solution is an end-to-end managed service that gives covered entities the opportunity to capture increased 340B savings.

"Disproportionate Share Hospitals (DSH) can benefit from a 340B program," said Carla Corkern, Chief Executive Officer at Talyst. "Through their additional savings from Contract Pharmacy, the DSH can provide better and safer care to their patients."

Talyst will be exhibiting at the Coalition in booth #33. For more information on the conference, visit http://www.340bcoalition.org/conferences/2012_annual/index.cfm.

About Talyst

Talyst is a leader in pharmacy automation and engineers the safer pharmacy. Our solutions provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than 600 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. We offer a powerful software platform with a suite of hardware components to meet your specific needs. Follow us on Twitter @Talyst_Inc or visit us at, www.talyst.com.


'/>"/>
SOURCE Talyst
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Talyst Announces New Automated Medication Packager
2. KALO Announces Distribution Areas
3. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
4. Medivir Announces an Interferon-Free Phase II Combination Trial With TMC435 and daclatasvir to Commence Shortly
5. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
6. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
7. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
8. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
9. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
10. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
11. Detroit Metro Convention & Visitors Bureau announces launch of Medical Meetings Initiative; recruits top leaders to Advisory Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... England , March 28, 2017 ... collaborative research with Cambridge ... Therapeutics Consortium   The Milner Therapeutics Institute today ... Consortium. Elysium Health has committed significant investment for collaborative projects ... the next four years. This is the first major research ...
(Date:3/27/2017)... , March 27, 2017 ... better understand Eli Lilly and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Columbus OH. ... selected as one of few medical professionals in the country to sit on the ... of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic from ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant ... Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System to ... adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. ...
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium in ... and offered an opportunity to collaborate and network with healthcare colleagues across the United ... gathered for a lively discussion on trends and issues that healthcare leaders will face ...
(Date:3/28/2017)... ... ... Bacteria and fungi are probably not the first ingredients that come to mind when thinking ... in your diet can actually improve health outcomes. And the good news is they may ... a new peer-reviewed paper led by Maria Marco, Ph.D. , University of ...
Breaking Medicine News(10 mins):